Standout Papers

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer 2002 2026 2010 2018 4.0k
  1. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer (2002)
    Joan H. Schiller, David Harrington et al. New England Journal of Medicine
  2. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment (2003)
    Andy Trotti, Valerie W. Rusch et al. Seminars in Radiation Oncology
  3. Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2004)
    David H. Johnson, Louis Fehrenbacher et al. Journal of Clinical Oncology
  4. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study (2016)
    Corey J. Langer, Shirish M. Gadgeel et al. The Lancet Oncology
  5. Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410 (2011)
    Walter J. Curran, Rebecca Paulus et al. JNCI Journal of the National Cancer Institute
  6. Laryngeal Cancer in the United States: Changes in Demographics, Patterns of Care, and Survival (2006)
    Henry T. Hoffman, Kimberly R. Porter et al. The Laryngoscope
  7. Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial (2017)
    Dong‐Wan Kim, Marcello Tiseo et al. Journal of Clinical Oncology
  8. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (2017)
    Stephen Bagley, Shawn Kothari et al. Lung Cancer
  9. Sotorasib with panitumumab in chemotherapy-refractory KRASG12C-mutated colorectal cancer: a phase 1b trial (2024)
    Yasutoshi Kuboki, Marwan Fakih et al. Nature Medicine

Immediate Impact

4 by Nobel laureates 5 from Science/Nature 104 standout
Sub-graph 1 of 17

Citing Papers

Radiotherapy toxicities: mechanisms, management, and future directions
2025 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
20 intermediate papers

Works of Corey J. Langer being referenced

Abstract 2308: Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC)
2023
Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma
2020
and 14 more

Author Peers

Author Last Decade Papers Cites
Corey J. Langer 16729 17063 5718 556 27.9k
David R. Gandara 18069 16654 7907 641 29.1k
Egbert F. Smit 17600 14478 7242 679 28.4k
Jacek Jassem 7771 11155 4695 510 19.3k
Jean‐Pierre Pignon 15967 14491 3945 305 30.3k
Steven E. Schild 11853 7870 3514 635 21.4k
Everett E. Vokes 15215 18801 9449 767 35.5k
Janet Dancey 15054 19412 8425 202 37.3k
Eric K. Rowinsky 9456 18262 11946 392 31.5k
James E. Herndon 14922 13208 7940 477 36.7k
Jack A. Roth 15994 12684 13218 650 35.9k

All Works

Loading papers...

Rankless by CCL
2026